Skip to main content
SEEGENE, INC. logo

SEEGENE, INC. — Investor Relations & Filings

Ticker · 096530 ISIN · KR7096530001 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2025-02-26 Earnings Release
Country KR South Korea
Listing KO 096530

About SEEGENE, INC.

https://www.seegene.com/

Seegene, Inc. is a company specializing in molecular diagnostics. It develops and manufactures in vitro diagnostic (IVD) products and automated systems based on its proprietary multiplex real-time PCR technologies. These technologies enable the simultaneous detection of multiple pathogens from a single sample, facilitating a syndromic testing approach for various conditions. The company's portfolio includes a broad range of diagnostic assays for infectious diseases, including respiratory illnesses, sexually transmitted infections (STIs), and human papillomavirus (HPV). Seegene also provides automated platforms, such as its All-in-One systems, to streamline laboratory workflows. The company engages in technology-sharing initiatives and strategic collaborations to advance the standardization and accessibility of molecular diagnostics globally.

Recent filings

Filing Released Lang Actions
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Seegene, detailing quarterly financial performance (revenue, operating profit, net income) for the 4th quarter of 2024. It provides key financial highlights in a table format, which is characteristic of an initial earnings announcement rather than a full annual report or a transcript. It explicitly states these are provisional figures and refers to future detailed disclosures, fitting the definition of an Earnings Release (ER). Q4 2024
2025-02-26 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from Seegene regarding a significant change in financial structure (revenue/profit/loss) exceeding 15% for a large corporation. It provides preliminary financial results (sales, operating profit, net income) for the fiscal year compared to the previous year. This is a standard 'Earnings Release' (ER) filing in the Korean market, where companies disclose preliminary financial performance before the final audited annual report is published. FY 2024
2025-02-26 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange. It specifically details a 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정) for the purpose of acquiring shares in another company (DandiMeca). According to the provided definitions, the category 'Transaction in Own Shares' (POS) covers reports of a company buying back or selling its own shares (share repurchase/issuance). This document is a direct disclosure of such a transaction.
2025-02-25 Korean
결산실적공시예고
Report Publication Announcement Classification · 100% confidence The document is a short announcement (563 characters) from Seegene notifying the market of the upcoming release date for its 2024 annual financial results. It explicitly states the 'expected date of disclosure' (2025-02-26) and mentions that the actual financial data will be published on that future date. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, making it a Report Publication Announcement (RPA).
2025-02-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from Seegene regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming 25th Annual General Meeting. It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of a corporate action (setting a record date). Given the nature of the announcement as a regulatory disclosure regarding shareholder rights and meeting preparation, it fits best under the general regulatory filing category.
2024-12-16 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식처분결과보고서' (Report on the Results of Disposal of Treasury Shares) filed with the Financial Supervisory Service (FSS) of South Korea. It details the specific number of shares disposed of, the disposal period, and the resulting change in the company's treasury share holdings. This falls under the category of a company reporting the sale or disposal of its own shares, which corresponds to the 'Transaction in Own Shares' (POS) category.
2024-12-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.